» Articles » PMID: 29312491

MicroRNA-34a Promotes Cell Cycle Arrest and Apoptosis and Suppresses Cell Adhesion by Targeting DUSP1 in Osteosarcoma

Overview
Journal Am J Transl Res
Specialty General Medicine
Date 2018 Jan 10
PMID 29312491
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs are often deregulated in most cancer types and have important functions in carcinogenesis and cancer progression. Here, we studied the function of microRNA-34 (miR-34a) in osteosarcoma MG63 and U-2OS cells by expressed with pre-miR-34a, anti-miR-34a and corresponding negative controls, respectively. Cells proliferation, cell cycle and apoptosis was measured by MTT and flow cytometry assay. The effect of miR-34a on DUSP1 expression was evaluated by luciferase assays, real-time PCR and western blot assay. The data showed that miR-34a reduced the proliferation of MG63 cells through prompting cell cycle arrest at G0/G1 phase, cell apoptosis, and suppressed cell adhesion ability. Whereas anti-miR-34a increases U-2OS cell proliferation by preventing cell apoptosis, and promotes cell adhesion. Finally, we identified Dual-specificity phosphatase 1 (DUSP1) as the target gene of miR-34a in osteosarcoma cells and confirmed that DUSP1 enhanced the proliferation through inhibiting cell cycle arrest at G0/G1 phase and apoptosis, and inhibits the decreased cell adhesion induced by miR-34a. However, inhibition of DUSP1 resulted in substantially decreased proliferation and adhesion, and cell cycle arrest in G0/G1 phase and cell apoptosis similar to that observed with miR-34a in U-2OS cells. Our findings find out an important function of miR-34a as a novel tumor-suppressor in osteosarcoma pathogenesis through inhibition of DUSP1.

Citing Articles

Expression profile of mRNAs and miRNAs related to mitogen-activated kinases in HaCaT cell culture treated with lipopolysaccharide a and adalimumab.

Wojcik M, Plata-Babula A, Glowaczewska A, Sirek T, Orczyk A, Malecka M Cell Cycle. 2024; 23(4):385-404.

PMID: 38557266 PMC: 11174132. DOI: 10.1080/15384101.2024.2335051.


Gene expression profile of mitogen-activated kinases and microRNAs controlling their expression in HaCaT cell culture treated with lipopolysaccharide A and cyclosporine A.

Wojcik M, Zmarzly N, Derkacz A, Kulpok-Baginski T, Blek N, Grabarek B Cell Cycle. 2024; 23(3):279-293.

PMID: 38445655 PMC: 11057563. DOI: 10.1080/15384101.2024.2320508.


MiR-659-3p inhibits osteosarcoma progression and metastasis by inhibiting cell proliferation and invasion via targeting SRPK1.

Gong Y, Wei Z BMC Cancer. 2022; 22(1):934.

PMID: 36038837 PMC: 9425973. DOI: 10.1186/s12885-022-10029-0.


Research Progress of Exosome-Loaded miRNA in Osteosarcoma.

Yao P, Lu Y, Cai Z, Yu T, Kang Y, Zhang Y Cancer Control. 2022; 29:10732748221076683.

PMID: 35179996 PMC: 8859673. DOI: 10.1177/10732748221076683.


Epi-miRNAs: Regulators of the Histone Modification Machinery in Human Cancer.

Mortazavi D, Sohrabi B, Mosallaei M, Nariman-Saleh-Fam Z, Bastami M, Mansoori Y J Oncol. 2022; 2022:4889807.

PMID: 35087589 PMC: 8789461. DOI: 10.1155/2022/4889807.


References
1.
Keyse S . Dual-specificity MAP kinase phosphatases (MKPs) and cancer. Cancer Metastasis Rev. 2008; 27(2):253-61. DOI: 10.1007/s10555-008-9123-1. View

2.
Minami K, Taniguchi K, Sugito N, Kuranaga Y, Inamoto T, Takahara K . MiR-145 negatively regulates Warburg effect by silencing KLF4 and PTBP1 in bladder cancer cells. Oncotarget. 2017; 8(20):33064-33077. PMC: 5464850. DOI: 10.18632/oncotarget.16524. View

3.
Wang L, Yang L, Lu Y, Chen Y, Liu T, Peng Y . Osthole Induces Cell Cycle Arrest and Inhibits Migration and Invasion via PTEN/Akt Pathways in Osteosarcoma. Cell Physiol Biochem. 2016; 38(6):2173-82. DOI: 10.1159/000445573. View

4.
Wang Q, Shi S, He W, Padilla M, Zhang L, Wang X . Retaining MKP1 expression and attenuating JNK-mediated apoptosis by RIP1 for cisplatin resistance through miR-940 inhibition. Oncotarget. 2014; 5(5):1304-14. PMC: 4012727. DOI: 10.18632/oncotarget.1798. View

5.
Shaker O, Mohammed S, Mohammed A, Mahmoud Z . Impact of microRNA-375 and its target gene SMAD-7 polymorphism on susceptibility of colorectal cancer. J Clin Lab Anal. 2017; 32(1). PMC: 6817095. DOI: 10.1002/jcla.22215. View